ATMP Conference Malmö 2024: A Catalyst for Innovation in Lund
The ATMP Sweden 2024 conference in Malmö, held on 25–26 November, showcased critical advancements and strategic frameworks shaping the future of Advanced Therapy Medicinal Products (ATMPs). Bringing together leading experts, researchers, and stakeholders, the event highlighted the latest scientific breakthroughs and practical approaches to ATMP development. Excellent presentations and structured collaborations emphasised the importance of fostering innovation and building partnerships within the ATMP ecosystem.
ATMP treatments represent a transformative leap in medicine, offering hope to patients with conditions that traditional therapies struggle to address. Events like the ATMP Sweden 2024 conference spotlight the progress and potential of these therapies, bringing together stakeholders to share knowledge and foster partnerships.
The conference highlighted notable achievements, including the STEM-PD trial for Parkinson’s disease and advancements in gene editing and tissue engineering. These developments underscore the transformative potential of ATMPs, particularly in clinical areas such as neurology, oncology, and haematology. Discussions also addressed the value of diversity in leadership, with Sarah Lidé from Medicon Village Innovation presenting strategies to harness international expertise in the life sciences sector.
Lund and the Skåne region are rapidly establishing themselves as a hub for ATMP innovation. This dynamic environment is driven by close collaboration between academia, biotech companies, and healthcare institutions, enabling groundbreaking developments in cell and gene therapies and personalised medicine. State-of-the-art laboratories, incubators, and a strategic location within the Medicon Valley region further bolster Lund’s capacity to accelerate the clinical application and commercialisation of ATMPs.
Medicon Village plays a pivotal role in Lund’s thriving ATMP ecosystem, bridging groundbreaking research and commercial success. In collaboration with Smile Incubator, Lund University Innovation, and Skåne University Hospital, it provides essential resources, infrastructure, and strategic support to transform university-driven innovations into viable companies. This dynamic network fuels cutting-edge research, innovation, and collaboration across academia, healthcare, and industry, positioning Lund at the forefront of advanced therapy development.
Pictured from left to right: Thomas Areschoug, Business Coach & Industry Relations, SmiLe Venture Hub; Cecilia Jädert, Innovation Developer, LU Innovation; and Francesco Bez, Innovation Manager, Medicon Village Innovation.